BLFS Stock Summary and Trading Ideas (Biolife Solutions | NASDAQ:BLFS)

BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.

Biolife Solutions trades on the NASDAQ stock market under the symbol BLFS.

As of August 18, 2026, BLFS stock price declined to $34.87 with 144,992 million shares trading.

BLFS has a beta of 0.99, meaning it tends to be less sensitive to market movements. BLFS has a correlation of 0.07 to the broad based SPY ETF.

BLFS has a market cap of $1.70 billion. This is considered a Small Cap stock.

Last quarter Biolife Solutions reported $28 million in Revenue and $.08 earnings per share. This beat revenue expectation by $898,576 and exceeded earnings estimates by $.04.

In the last 3 years, BLFS traded as high as $35.46 and as low as $8.92.

The top ETF exchange traded funds that BLFS belongs to (by Net Assets): IJR, VTI, IWM, VXF, SPSM.

BLFS has outperformed the market in the last year with a price return of +43.3% while the SPY ETF gained +20.6%. BLFS has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +68.0% and +8.5%, respectively, while the SPY returned +4.2% and +1.4%, respectively.

BLFS support price is $34.50 and resistance is $36.40 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BLFS shares will trade within this expected range on the day.